Fibrinolysis in a nutshell
- PMID: 40760910
- DOI: 10.1111/bjh.70063
Fibrinolysis in a nutshell
Abstract
Fibrinolysis is the process by which fibrin, the principal proteinaceous component of blood clots, is enzymatically degraded. A key event in this process is the formation of the tissue plasminogen activator (tPA)-plasminogen complex on partially degraded fibrin, which leads to the conversion of plasminogen to plasmin, which then proteolytically digests fibrin. This system is tightly regulated by several inhibitors and by the clot architecture. Many components of the fibrinolytic system have roles beyond fibrinolysis (e.g. in ageing, basal metabolism, inflammation and cancer), but these will not be addressed in detail in this brief narrative.
Keywords: fibrin; fibrinolysis; plasmin; tranexamic acid.
© 2025 British Society for Haematology and John Wiley & Sons Ltd.
References
REFERENCES
-
- Wolberg AS. Thrombin generation and fibrin clot structure. Blood Rev. 2007;21(3):131–142.
-
- Longstaff C, Kolev K. Basic mechanisms and regulation of fibrinolysis. J Thromb Haemost. 2015;13(Suppl 1):S98–S105.
-
- Andronicos NM, Chen EI, Baik N, Bai H, Parmer CM, Kiosses WB, et al. Proteomics‐based discovery of a novel, structurally unique, and developmentally regulated plasminogen receptor, Plg‐RKT, a major regulator of cell surface plasminogen activation. Blood. 2010;115(7):1319–1330.
-
- Urano T, Castellino FJ, Suzuki Y. Regulation of plasminogen activation on cell surfaces and fibrin. J Thromb Haemost. 2018;16(8):1487–1497.
-
- Humphreys SJ, Whyte CS, Mutch NJ. “Super” SERPINs—a stabilizing force against fibrinolysis in thromboinflammatory conditions. Front Cardiovasc Med. 2023;10:1146833.
Publication types
LinkOut - more resources
Full Text Sources